July 01, 2024
The information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.
On June 25, 2024, Glenmark Pharmaceuticals, Inc. recalled numerous lots of potassium chloride extended-release 750mg capsules from the consumer level. Additionally, on June 26, 2024, American Health Packaging issued a recall for the same medication. The recalls were initiated due to concerns that the capsules might not dissolve properly, leading to higher potassium blood levels. This can result in irregular heartbeat or cardiac arrest. Potassium chloride is an essential mineral supplement used to treat individuals with low blood levels of potassium. For the FDA notices, see here and here.
Last updated: July 01, 2024